Chrystal Louis
Technik-/Wissenschafts-/F&E-Leiter bei TSCAN THERAPEUTICS, INC.
Profil
Chrystal U.
Louis is currently the Chief Medical Officer at TScan Therapeutics, Inc. He previously worked as the Executive Director-Myeloid Diseases at Celgene Corp from 2018 to 2019, as the Vice President & Head-Medical Affairs at CRISPR Therapeutics, Inc. from 2020 to 2022, and as the Senior VP-Hematology Clinical Development at Zentalis Pharmaceuticals, Inc. from 2022 to 2024.
Dr. Louis holds a graduate degree from Tulane University School of Public Health & Tropical Medicine, a doctorate degree from Tulane University School of Medicine, and an undergraduate degree from Southwestern University.
Aktive Positionen von Chrystal Louis
| Unternehmen | Position | Beginn |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.04.2024 |
Ehemalige bekannte Positionen von Chrystal Louis
| Unternehmen | Position | Ende |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2024 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Corporate Officer/Principal | 01.11.2022 |
| CELGENE | Corporate Officer/Principal | 01.01.2019 |
Ausbildung von Chrystal Louis
| Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
| Southwestern University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
